CN108635334A - A kind of novel Dequalinium Chloride lozenge and preparation method thereof - Google Patents

A kind of novel Dequalinium Chloride lozenge and preparation method thereof Download PDF

Info

Publication number
CN108635334A
CN108635334A CN201810839163.7A CN201810839163A CN108635334A CN 108635334 A CN108635334 A CN 108635334A CN 201810839163 A CN201810839163 A CN 201810839163A CN 108635334 A CN108635334 A CN 108635334A
Authority
CN
China
Prior art keywords
parts
dequalinium chloride
novel
lozenge
pigment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810839163.7A
Other languages
Chinese (zh)
Inventor
刘经星
牛春霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANHUI HEAL STAR PHARMACEUTICAL CO LTD
Original Assignee
ANHUI HEAL STAR PHARMACEUTICAL CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANHUI HEAL STAR PHARMACEUTICAL CO LTD filed Critical ANHUI HEAL STAR PHARMACEUTICAL CO LTD
Priority to CN201810839163.7A priority Critical patent/CN108635334A/en
Publication of CN108635334A publication Critical patent/CN108635334A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of novel Dequalinium Chloride lozenges and preparation method thereof, including:Dequalinium Chloride, mannitol, maltitol, acesulfame potassium, citric acid, liquid extract of liquorice, methyl p-hydroxybenzoate, menthol, lac, pigment, adhesive, antioxidant.Method:1)Mannitol, maltitol, acesulfame potassium and liquid extract of liquorice add water and mix to obtain solution A;2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and antioxidant mixing, obtain material B;3)By solution A and material B wet mixings, wet granular is made;4)Wet granular is dried;5)Tabletting;6)Make pure shellac solution;7)By pure shellac solution=be applied to step 5)Gained Dequalinium Chloride preform outer surface, it is dry.The present invention solves the disadvantage that the edible impression of Dequalinium Chloride lozenge in the prior art is poor, drug effect is difficult to give full play to, has stronger replicability well by relatively simple manufacture craft and lower cost of manufacture.

Description

A kind of novel Dequalinium Chloride lozenge and preparation method thereof
Technical field
The present invention relates to pharmaceutical technology fields, and in particular to a kind of novel Dequalinium Chloride lozenge and preparation method thereof.
Background technology
Dequalinium Chloride is also known as Dequavet dequaline chloride, is cationic surfactant, has broad-spectrum antibacterial action, to oral cavity It is effective with pharyngeal common pathogen and fungal infection, therefore be usually used in acute laryngopharyngitis, oral disinfecting etc..
Dequalinium Chloride lozenge is a kind of contained in oral cavity and the compressed tablets of slow mechanism dissolved, can to oral cavity and pharyngeal generation compared with For lasting drug effect, it to be used for topical anti-inflammatory, disinfection etc..Dequalinium Chloride lozenge due to it is convenient to take, have preferable mouthfeel and by To the welcome of many patients.Change due to slowly containing, so that the drug long period is rested on pharyngeal, persistently play drug effect.
But the melting time of Dequalinium Chloride lozenge in the prior art is shorter, therefore patient needs fairly frequently to take Drug is simultaneously taken again, this not only bad for drug effect lasting performance, and high frequency time take medication object also brought not to patient Just;In addition, after the Dequalinium Chloride lozenge sold at present takes entrance for a period of time, it will usually generate a kind of not satiny, puckery Bad mouthfeel, give user poor mouthfeel, be easy to cause and take resentment, to be difficult to be accepted by patients, be unfavorable for It promotes.
Chinese patent CN106632031A discloses the preparation method of a kind of Dequalinium Chloride crystal and its lozenge and lozenge, ground Quinoline oronain lozenge is made of the following raw material medicine:Dequalinium Chloride crystal 0.01-0.03 parts by weight, mannitol 45-50 parts by weight, xylose Alcohol 45-50 parts by weight, sodium carboxymethylcellulose 1.0-2.0 parts by weight, chlorophyll copper sodium 0.005-0.02 parts by weight, para hydroxybenzene Methyl formate 0.002-0.006 parts by weight, liquid extract of liquorice 0.4-0.6 parts by weight, strawberry essence 0.2-0.5 parts by weight, peppermint Brain 0.3-0.5 parts by weight, aspartame 0.3-0.5 parts by weight, silica 0.3-0.5 parts by weight, polyethylene glycol-6000 1.0- 2.0 parts by weight and magnesium stearate 0.3-0.5 parts by weight.The solution rate of other each ingredients of the Dequalinium Chloride lozenge is consistent, will not Generate the feeling of " puckery ";The stability of the Dequalinium Chloride lozenge of the present invention is preferable, and storing active ingredient for a long time will not decline. But the Dequalinium Chloride lozenge preparation condition is more harsh, preparation process is complex, and cost is higher.
Chinese patent CN106727369A discloses a kind of Dequalinium Chloride lozenge and preparation method thereof, Dequalinium Chloride lozenge by Following ingredients form:Sucrose 80-95 parts by weight, mannitol 1.5-2.5 parts by weight, stearic acid 0.15-0.4 parts by weight, pigment 0.005-0.01 parts by weight, Dequalinium Chloride 0.01-0.025 parts by weight, liquid extract of liquorice 0.3-0.5 parts by weight, para hydroxybenzene first Sour methyl esters 0.002-0.004 parts by weight, gelatin 1-3 parts by weight, menthol 0.1-0.3 parts by weight, essence 0.1-0.3 parts by weight, Magnesium stearate 0.1-0.35 parts by weight, sodium carboxymethylcellulose 0.5-1.5 parts by weight.Dequalinium Chloride lozenge melting time length, Lasting medicine.But patient often chews pharynx or swallows or directly during take because it needs to suck overlong time selection Selecting, which is selected, to be abandoned, and causes the actual efficacy of drug that can not play.
Invention content
For problems of the prior art, the present invention provides a kind of novel Dequalinium Chloride lozenge and its preparation sides Method, the present invention solve the disadvantage that the edible impression of Dequalinium Chloride lozenge in the prior art is poor, drug effect is difficult to give full play to.
In order to achieve the above object, the present invention is achieved through the following technical solutions:
A kind of novel Dequalinium Chloride lozenge, includes the raw material of following parts by weight meter:0.015-0.025 parts of Dequalinium Chloride, mannitol 10-13 parts, 5-12 parts of maltitol, 10-20 parts of acesulfame potassium, 2-5 parts of citric acid, 1-3 parts of liquid extract of liquorice, P-hydroxybenzoic acid 0.015-0.05 parts of methyl esters, 2-3 parts of menthol, 5-8 parts of lac, 0.5-1.2 parts of pigment, 0.5-0.8 parts of adhesive, antioxidant 1-3 parts.
Preferably, include the raw material of following parts by weight meter:0.015 part of Dequalinium Chloride, 10 parts of mannitol, 5 parts of maltitol, 10 parts of acesulfame potassium, 2 parts of citric acid, 1 part of liquid extract of liquorice, 0.015 part of methyl p-hydroxybenzoate, 2 parts of menthol, 5 parts of lac, 0.5 part of pigment, 0.5 part of adhesive, 1 part of antioxidant.
Preferably, include the raw material of following parts by weight meter:0.025 part of Dequalinium Chloride, 13 parts of mannitol, maltitol 12 Part, 20 parts of acesulfame potassium, 5 parts of citric acid, 3 parts of liquid extract of liquorice, 0.05 part of methyl p-hydroxybenzoate, 3 parts of menthol, lac 8 Part, 1.2 parts of pigment, 0.8 part of adhesive, 3 parts of antioxidant.
Preferably, include the raw material of following parts by weight meter:0.020 part of Dequalinium Chloride, 12 parts of mannitol, maltitol 10 Part, 15 parts of acesulfame potassium, 4 parts of citric acid, 2 parts of liquid extract of liquorice, 0.03 part of methyl p-hydroxybenzoate, 2.5 parts of menthol, lac 6 parts, 1 part of pigment, 0.6 part of adhesive, 2 parts of antioxidant.
Preferably, pigment is one or more in gardenia blue, alkermes, safflower yellow.
Preferably, adhesive is povidone k30, hydroxypropyl methylcellulose, microcrystalline cellulose with mass ratio are 1:1:1.5 it is mixed Close object.
Preferably, it with mass ratio is 1 that antioxidant, which is D-araboascorbic acid, glutathione,:2 mixture.
The preparation method that novel Dequalinium Chloride lozenge is also disclosed in the present invention, includes the following steps:
1)Deionized water ultrasonication 5- is added in mannitol, maltitol, acesulfame potassium and the liquid extract of liquorice for weighing formula ratio 8min, and it is heated to 50-60 DEG C of heat preservation, uniformly mixed solution A is obtained, it is spare;
2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and the antioxidant of formula ratio is taken to pour into more The mixed processing 5-10min into movement mixer obtains material B;
3)Solution A and material B are poured into wet mixing 10min in high-speed mixing granulating machine, suitable softwood is made after mixing;It will The softwood made is added in oscillating granulator through sieve, and wet granular is made;
4)Wet granular is laid in baking material disk to be placed in heated-air circulation oven, is 2-3MPa in steam pressure, temperature is 70-80 DEG C Under conditions of dry 5-6h;
5)Material oscillating granulator whole grain after drying, sieve mesh number are 10 mesh, and dry particl is made, is pressed using tablet press machine Piece obtains Dequalinium Chloride preform;
6)The lac of parts by weight is taken to be dissolved with 50% ethyl alcohol, filtering removal insoluble matter takes filtrate, evaporative removal ethyl alcohol to obtain Pure shellac solution;
7)By step 6)Obtained pure shellac solution is uniformly applied to step 5)The Dequalinium Chloride preform outer surface of gained, very Novel Dequalinium Chloride lozenge is drying to obtain under Altitude.
Preferably, step 7)In pure shellac solution be applied to Dequalinium Chloride preform outer surface thickness be 0.03- 0.05mm。
Preferably, step 7)Novel Dequalinium Chloride lozenge obtained is packed using aluminum foil under vacuum.
The present invention has following advantageous effect:
1, novel Dequalinium Chloride lozenge disclosed by the invention is that primary sweetener assists addition sweet dew simultaneously by the way that acesulfame potassium is arranged As sweetener, acesulfame potassium is a kind of food additives, soluble easily in water, can increase food for alcohol, maltitol and liquid extract of liquorice Product sweet taste, nonnutritive, in good taste, empty calory, have be not metabolized, do not absorb in human body, be the middle-aged and the old, adiposis patient, The ideal sweetener of diabetic;Acesulfame potassium and other sweeteners, which are used in mixed way, simultaneously can generate very strong synergistic effect, and one As can increase sugariness 30% ~ 50% under concentration, largely improve Dequalinium Chloride lozenge, avoid people containing being generated after the long period Undesirable experience, and then medication time is influenced, lead to the situation that drug effect is undesirable.
2, by the way that in the pure lac of Dequalinium Chloride lozenge outer surface even application, the stabilization of Dequalinium Chloride lozenge can be increased Property, the preservation long period will not go bad after production, and then can produce in enormous quantities, improve production efficiency.
3, the Dequalinium Chloride lozenge after production is completed is packed using aluminum foil under vacuum, can further prevent air quinoline over the ground The oxidation of oronain lozenge, the further pot-life for extending drug.
In conclusion a kind of novel Dequalinium Chloride lozenge disclosed by the invention and preparation method thereof, by relatively simple Manufacture craft and lower cost of manufacture solve the poor, medicine of the edible impression of Dequalinium Chloride lozenge in the prior art well The shortcomings that effect is difficult to give full play to has stronger replicability.
Specific implementation mode
The specific implementation mode of the present invention is further described with reference to embodiment, following embodiment is only used for more Technical scheme of the present invention is clearly demonstrated, and not intended to limit the protection scope of the present invention.
Embodiment 1
A kind of novel Dequalinium Chloride lozenge, includes the raw material of following parts by weight meter:0.015 part of Dequalinium Chloride, 10 parts of mannitol, wheat 5 parts of bud sugar alcohol, 10 parts of acesulfame potassium, 2 parts of citric acid, 1 part of liquid extract of liquorice, 0.015 part of methyl p-hydroxybenzoate, menthol 2 Part, 5 parts of lac, 0.5 part of pigment, 0.5 part of adhesive, 1 part of antioxidant.
Wherein, pigment is gardenia blue, alkermes with the mixture of arbitrary proportion.
Wherein, adhesive is povidone k30, hydroxypropyl methylcellulose, microcrystalline cellulose with mass ratio are 1:1:1.5 mixing Object.
Wherein, it with mass ratio is 1 that antioxidant, which is D-araboascorbic acid, glutathione,:2 mixture.
A kind of preparation method of novel Dequalinium Chloride lozenge, includes the following steps:
1)Deionized water ultrasonication is added in mannitol, maltitol, acesulfame potassium and the liquid extract of liquorice for weighing formula ratio 5min, and 50 DEG C of heat preservations are heated to, uniformly mixed solution A is obtained, it is spare;
2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and the antioxidant of formula ratio is taken to pour into more The mixed processing 5min into movement mixer obtains material B;
3)Solution A and material B are poured into wet mixing 10min in high-speed mixing granulating machine, suitable softwood is made after mixing;It will The softwood made is added in oscillating granulator through sieve, and wet granular is made;
4)Wet granular is laid in baking material disk to be placed in heated-air circulation oven, is 2MPa, the item that temperature is 70 DEG C in steam pressure Dry 5h under part;
5)Material oscillating granulator whole grain after drying, sieve mesh number are 10 mesh, and dry particl is made, is pressed using tablet press machine Piece obtains Dequalinium Chloride preform;
6)The lac of parts by weight is taken to be dissolved with 50% ethyl alcohol, filtering removal insoluble matter takes filtrate, evaporative removal ethyl alcohol to obtain Pure shellac solution;
7)By step 6)Obtained pure shellac solution is uniformly applied to step 5)The Dequalinium Chloride preform outer surface of gained, very Novel Dequalinium Chloride lozenge is drying to obtain under Altitude, the thickness of smearing is 0.03mm, and novel Dequalinium Chloride lozenge obtained is adopted It is packed with aluminum foil under vacuum.
Embodiment 2
A kind of novel Dequalinium Chloride lozenge, includes the raw material of following parts by weight meter:0.025 part of Dequalinium Chloride, 13 parts of mannitol, wheat 12 parts of bud sugar alcohol, 20 parts of acesulfame potassium, 5 parts of citric acid, 3 parts of liquid extract of liquorice, 0.05 part of methyl p-hydroxybenzoate, menthol 3 Part, 8 parts of lac, 1.2 parts of pigment, 0.8 part of adhesive, 3 parts of antioxidant.
Wherein, pigment is gardenia blue.
Wherein, adhesive is povidone k30, hydroxypropyl methylcellulose, microcrystalline cellulose with mass ratio are 1:1:1.5 mixing Object.
Wherein, it with mass ratio is 1 that antioxidant, which is D-araboascorbic acid, glutathione,:2 mixture.
A kind of preparation method of novel Dequalinium Chloride lozenge, includes the following steps:
1)Deionized water ultrasonication is added in mannitol, maltitol, acesulfame potassium and the liquid extract of liquorice for weighing formula ratio 8min, and 60 DEG C of heat preservations are heated to, uniformly mixed solution A is obtained, it is spare;
2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and the antioxidant of formula ratio is taken to pour into more The mixed processing 10min into movement mixer obtains material B;
3)Solution A and material B are poured into wet mixing 10min in high-speed mixing granulating machine, suitable softwood is made after mixing;It will The softwood made is added in oscillating granulator through sieve, and wet granular is made;
4)Wet granular is laid in baking material disk to be placed in heated-air circulation oven, is 3MPa, the item that temperature is 80 DEG C in steam pressure Dry 6h under part;
5)Material oscillating granulator whole grain after drying, sieve mesh number are 10 mesh, and dry particl is made, is pressed using tablet press machine Piece obtains Dequalinium Chloride preform;
6)The lac of parts by weight is taken to be dissolved with 50% ethyl alcohol, filtering removal insoluble matter takes filtrate, evaporative removal ethyl alcohol to obtain Pure shellac solution;
7)By step 6)Obtained pure shellac solution is uniformly applied to step 5)The Dequalinium Chloride preform outer surface of gained, very Novel Dequalinium Chloride lozenge is drying to obtain under Altitude, the thickness of smearing is 0.05mm, and novel Dequalinium Chloride lozenge obtained is adopted It is packed with aluminum foil under vacuum.
Embodiment 3
A kind of novel Dequalinium Chloride lozenge, includes the raw material of following parts by weight meter:0.020 part of Dequalinium Chloride, 12 parts of mannitol, wheat 10 parts of bud sugar alcohol, 15 parts of acesulfame potassium, 4 parts of citric acid, 2 parts of liquid extract of liquorice, 0.03 part of methyl p-hydroxybenzoate, menthol 2.5 parts, 6 parts of lac, 1 part of pigment, 0.6 part of adhesive, 2 parts of antioxidant.
Wherein, pigment is safflower yellow.
Wherein, adhesive is povidone k30, hydroxypropyl methylcellulose, microcrystalline cellulose with mass ratio are 1:1:1.5 mixing Object.
Wherein, it with mass ratio is 1 that antioxidant, which is D-araboascorbic acid, glutathione,:2 mixture.
A kind of preparation method of novel Dequalinium Chloride lozenge, includes the following steps:
1)Deionized water ultrasonication is added in mannitol, maltitol, acesulfame potassium and the liquid extract of liquorice for weighing formula ratio 7min, and 55 DEG C of heat preservations are heated to, uniformly mixed solution A is obtained, it is spare;
2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and the antioxidant of formula ratio is taken to pour into more The mixed processing 8min into movement mixer obtains material B;
3)Solution A and material B are poured into wet mixing 10min in high-speed mixing granulating machine, suitable softwood is made after mixing;It will The softwood made is added in oscillating granulator through sieve, and wet granular is made;
4)Wet granular is laid in baking material disk to be placed in heated-air circulation oven, is 3MPa, the item that temperature is 75 DEG C in steam pressure Dry 6h under part;
5)Material oscillating granulator whole grain after drying, sieve mesh number are 10 mesh, and dry particl is made, is pressed using tablet press machine Piece obtains Dequalinium Chloride preform;
6)The lac of parts by weight is taken to be dissolved with 50% ethyl alcohol, filtering removal insoluble matter takes filtrate, evaporative removal ethyl alcohol to obtain Pure shellac solution;
7)By step 6)Obtained pure shellac solution is uniformly applied to step 5)The Dequalinium Chloride preform outer surface of gained, very Novel Dequalinium Chloride lozenge is drying to obtain under Altitude, the thickness of smearing is 0.04mm, and novel Dequalinium Chloride lozenge obtained is adopted It is packed with aluminum foil under vacuum.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, although with reference to aforementioned reality Applying example, invention is explained in detail, for those skilled in the art, still can be to aforementioned each implementation Technical solution recorded in example is modified or equivalent replacement of some of the technical features.All essences in the present invention With within principle, any modification, equivalent replacement, improvement and so on should all be included in the protection scope of the present invention god.

Claims (10)

1. a kind of novel Dequalinium Chloride lozenge, which is characterized in that include the raw material of following parts by weight meter:Dequalinium Chloride 0.015- 0.025 part, 10-13 parts of mannitol, 5-12 parts of maltitol, 10-20 parts of acesulfame potassium, 2-5 parts of citric acid, liquid extract of liquorice 1-3 Part, 0.015-0.05 parts of methyl p-hydroxybenzoate, 2-3 parts of menthol, 5-8 parts of lac, 0.5-1.2 parts of pigment, adhesive 0.5-0.8 parts, 1-3 parts of antioxidant.
2. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:Include the original of following parts by weight meter Material:0.015 part of Dequalinium Chloride, 10 parts of mannitol, 5 parts of maltitol, 10 parts of acesulfame potassium, 2 parts of citric acid, 1 part of liquid extract of liquorice, 0.015 part of methyl p-hydroxybenzoate, 2 parts of menthol, 5 parts of lac, 0.5 part of pigment, 0.5 part of adhesive, 1 part of antioxidant.
3. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:Include the original of following parts by weight meter Material:0.025 part of Dequalinium Chloride, 13 parts of mannitol, 12 parts of maltitol, 20 parts of acesulfame potassium, 5 parts of citric acid, liquid extract of liquorice 3 Part, 0.05 part of methyl p-hydroxybenzoate, 3 parts of menthol, 8 parts of lac, 1.2 parts of pigment, 0.8 part of adhesive, antioxidant 3 Part.
4. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:Include the original of following parts by weight meter Material:0.020 part of Dequalinium Chloride, 12 parts of mannitol, 10 parts of maltitol, 15 parts of acesulfame potassium, 4 parts of citric acid, liquid extract of liquorice 2 Part, 0.03 part of methyl p-hydroxybenzoate, 2.5 parts of menthol, 6 parts of lac, 1 part of pigment, 0.6 part of adhesive, antioxidant 2 Part.
5. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:The pigment is gardenia blue, rouge It is one or more in fat dried female insect, safflower yellow.
6. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:Described adhesive is povidone K30, hydroxypropyl methylcellulose, microcrystalline cellulose are with mass ratio for 1:1:1.5 mixture.
7. a kind of novel Dequalinium Chloride lozenge according to claim 1, it is characterised in that:The antioxidant is D- different anti- Bad hematic acid, glutathione are with mass ratio for 1:2 mixture.
8. a kind of preparation method of such as novel Dequalinium Chloride lozenge of claim 1-7 any one of them, which is characterized in that including Following steps:
1)Deionized water ultrasonication 5- is added in mannitol, maltitol, acesulfame potassium and the liquid extract of liquorice for weighing formula ratio 8min, and it is heated to 50-60 DEG C of heat preservation, uniformly mixed solution A is obtained, it is spare;
2)Dequalinium Chloride, methyl p-hydroxybenzoate, menthol, pigment, adhesive and the antioxidant of formula ratio is taken to pour into more The mixed processing 5-10min into movement mixer obtains material B;
3)Solution A and material B are poured into wet mixing 10min in high-speed mixing granulating machine, suitable softwood is made after mixing;It will The softwood made is added in oscillating granulator through sieve, and wet granular is made;
4)Wet granular is laid in baking material disk to be placed in heated-air circulation oven, is 2-3MPa in steam pressure, temperature is 70-80 DEG C Under conditions of dry 5-6h;
5)Material oscillating granulator whole grain after drying, sieve mesh number are 10 mesh, and dry particl is made, is pressed using tablet press machine Piece obtains Dequalinium Chloride preform;
6)The lac of parts by weight is taken to be dissolved with 50% ethyl alcohol, filtering removal insoluble matter takes filtrate, evaporative removal ethyl alcohol to obtain Pure shellac solution;
7)By step 6)Obtained pure shellac solution is uniformly applied to step 5)The Dequalinium Chloride preform outer surface of gained, very Novel Dequalinium Chloride lozenge is drying to obtain under Altitude.
9. preparation method according to claim 8, it is characterised in that:The step 7)In pure shellac solution be applied to ground The thickness of quinoline oronain preform outer surface is 0.03-0.05mm.
10. preparation method according to claim 8, it is characterised in that:The step 7)Novel Dequalinium Chloride obtained contains Piece is packed using aluminum foil under vacuum.
CN201810839163.7A 2018-07-27 2018-07-27 A kind of novel Dequalinium Chloride lozenge and preparation method thereof Pending CN108635334A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810839163.7A CN108635334A (en) 2018-07-27 2018-07-27 A kind of novel Dequalinium Chloride lozenge and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810839163.7A CN108635334A (en) 2018-07-27 2018-07-27 A kind of novel Dequalinium Chloride lozenge and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108635334A true CN108635334A (en) 2018-10-12

Family

ID=63760440

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810839163.7A Pending CN108635334A (en) 2018-07-27 2018-07-27 A kind of novel Dequalinium Chloride lozenge and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108635334A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110801437A (en) * 2019-11-26 2020-02-18 安徽恒星制药有限公司 Dequalinium chloride buccal tablet and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1437944A (en) * 2003-03-07 2003-08-27 武汉同济明治医药有限公司 Technology for producing Dekuiluan lozenge
JP2006232675A (en) * 2005-02-22 2006-09-07 Kowa Co Complex type solid preparation for dissolution in oral cavity
CN105919959A (en) * 2016-06-16 2016-09-07 安徽省逸欣铭医药科技有限公司 Dequalinium vaginal tablets and preparation method thereof
CN106632031A (en) * 2016-12-13 2017-05-10 珠海同源药业有限公司 Dequalinium chloride crystal and buccal tablet thereof, and preparation method of buccal tablet
CN106727369A (en) * 2016-11-21 2017-05-31 珠海同源药业有限公司 A kind of Dequalinium Chloride lozenge and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1437944A (en) * 2003-03-07 2003-08-27 武汉同济明治医药有限公司 Technology for producing Dekuiluan lozenge
JP2006232675A (en) * 2005-02-22 2006-09-07 Kowa Co Complex type solid preparation for dissolution in oral cavity
CN105919959A (en) * 2016-06-16 2016-09-07 安徽省逸欣铭医药科技有限公司 Dequalinium vaginal tablets and preparation method thereof
CN106727369A (en) * 2016-11-21 2017-05-31 珠海同源药业有限公司 A kind of Dequalinium Chloride lozenge and preparation method thereof
CN106632031A (en) * 2016-12-13 2017-05-10 珠海同源药业有限公司 Dequalinium chloride crystal and buccal tablet thereof, and preparation method of buccal tablet

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
南京药学院主编: "《药剂学》", 31 March 1978, 人民卫生出版社 *
郑俊民主编: "《药用高分子材料学》", 31 August 2004, 中国医药科技出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110801437A (en) * 2019-11-26 2020-02-18 安徽恒星制药有限公司 Dequalinium chloride buccal tablet and preparation method thereof

Similar Documents

Publication Publication Date Title
US6187336B1 (en) Process for producing a solid which is rapidly soluble in the oral cavity
US8545870B2 (en) Medicinal table with prolonged release of the active principle
US6060078A (en) Chewable tablet and process for preparation thereof
CN106420643B (en) A kind of chewable tablets and preparation method thereof containing vitamine C sodium
EP2480221B1 (en) Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
Pothu et al. Lozenges formulation and evaluation: A review
BR112020003235A2 (en) oral compositions and methods of preparing them
CN105106142B (en) It is a kind of containing according to lyophilized oral formulations of piperazine azoles and preparation method thereof
US11413251B2 (en) Gelatin product comprising a core component and method for producing same
CN108635334A (en) A kind of novel Dequalinium Chloride lozenge and preparation method thereof
CN105078910A (en) Freeze-dried oral preparation containing elopiprazole and preparation method of freeze-dried oral preparation
JP2017105844A (en) Internal composition
JP5195623B2 (en) Tablet confectionery
JP2010154769A (en) Polyphenol-containing granule or polyphenol-containing chewable tablet, and method for producing the tablet or the granule
JP5266487B2 (en) Multilayer structure for oral cavity and method for producing the same
JP4336074B2 (en) Hard sugar-coated tablets with good color and texture
CN111557925B (en) Processing technology of hollow capsule body
JP4379179B2 (en) Fast dissolving tablet confectionery with cooling sensation and method for producing the same
KR101497508B1 (en) Solid preparations containing Pelargonium sidoides extracts and silicic acid compound, and preparing method thereof
KR20150116569A (en) Tablet containing extract of unripened black raspberry and manufacturing method thereof
JP2005253474A (en) Formed body of green tea composition and method for producing the same
CN102948577A (en) Chewing gum having spleen invigorating and food digesting effects, and its preparation method
KR101515984B1 (en) A pill containing metallic salt of polystyrene sulfonate as an active ingredient and preparation method thereof
KR20150001348A (en) The composition for manufacturing a soft tablet and manufacturing method thereof
CN111084267A (en) Process for preparing xylo-oligosaccharide sugar block

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181012

RJ01 Rejection of invention patent application after publication